Identification of Potent Caspase-3 Inhibitors for Treatment of Multi- Neurodegenerative Diseases Using Pharmacophore Modeling and Docking Approaches

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|13|8|1346-1353

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.8, 2014-10, pp. : 1346-1353

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacophore Based 3D-QSAR Modeling and Molecular Docking of Leucettines as Potent Dyrk1A Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 8, 2013-10 ,pp. : 719-726

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Novel IRAK-4 Inhibitors Through Pharmacophore Modeling, Atom-based 3D-QSAR, Docking Strategies and Molecular Dynamics Simulation

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 9, 2016-11 ,pp. : 879-887

Bentham Science Publishers

Access to resources Recommend Favorite

Toward the Identification of Novel Carbonic Anhydrase XIV Inhibitors using 3D-QSAR Pharmacophore Model, Virtual Screening and Molecular Docking Study

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 4, 2014-05 ,pp. : 403-412

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophore Modeling, Docking and Molecular Dynamics Studies on Caspase-3 Activators Binding at β-Tubulin Site

By  

Current Computer - Aided Drug Design, Vol. 11, Iss. 1, 2015-01 ,pp. : 72-83

Bentham Science Publishers

Access to resources Recommend Favorite

Combined 3D-QSAR, Pharmacophore and Docking Studies on Benzenesulfonamide Derivatives as Potent 12-Lipoxygenase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 1, 2017-01 ,pp. : 74-82

Bentham Science Publishers

Access to resources Recommend Favorite